FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, ...

A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a neurologist explains the connection.

Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro may slash the risk of a disorder affecting nearly 7million ...

A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway found a 45% lower risk in ...

The study found Ozempic, ... The findings also suggest that treatment with semaglutide and similar drugs may be associated with a lower risk of dementia and can help reduce nicotine cravings.

GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric ...

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...

A study released Monday of 200,000 people in the U.S. taking GLP-1s suggested the drugs' potential benefits extend beyond those currently recognized, such as a lower risk of Alzheimer's disease.

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.